Dr. Peter Razeghi, M.D.
What this data tells you about Dr. Razeghi
Dr. Peter Razeghi is a cardiovascular disease in Cypress, TX, with 18 years in practice. Based on federal Medicare data, Dr. Razeghi performed 5,452 Medicare services across 3,185 unique beneficiaries.
Between the years covered by Open Payments, Dr. Razeghi received a total of $5,415 from 40 pharmaceutical and/or device companies across 262 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Razeghi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,016 | $93 | $200 |
| Hospital follow-up visit, moderate complexity | 714 | $64 | $300 |
| Regadenoson injection (Lexiscan) for heart stress test | 682 | $43 | $300 |
| Electrocardiogram (EKG), 12-lead | 644 | $10 | $95 |
| EKG interpretation and report | 290 | $7 | $35 |
| Infusion, normal saline solution, 250 cc | 248 | $0 | $10 |
| Echocardiogram, transthoracic | 244 | $156 | $800 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 211 | $56 | $300 |
| Prothrombin time test (blood clotting) | 170 | $4 | $15 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 157 | $667 | $1,332 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 155 | $1,928 | $4,500 |
| Initial hospital admission, high complexity | 154 | $138 | $552 |
| Office visit, established patient (20-29 min) | 153 | $59 | $155 |
| Nuclear medicine study of heart muscle blood flow by pet | 113 | $146 | $500 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 82 | $6 | $25 |
| Ultrasound of both sides of head and neck blood flow | 56 | $150 | $600 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 53 | $19 | $82 |
| New patient office visit (45-59 min) | 46 | $132 | $263 |
| New patient office visit (30-44 min) | 38 | $67 | $180 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 36 | $203 | $800 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 34 | $48 | $395 |
| Emergency department visit, high complexity | 22 | $144 | $200 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 21 | $41 | $65 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 20 | $338 | $3,000 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 20 | $78 | $522 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 17 | $17 | $55 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $11 | $55 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 17 | $10 | $20 |
| Transitional care management services for problem of at least moderate complexity | 11 | $166 | $400 |
| Transitional care management services for problem of high complexity | 11 | $225 | $500 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Razeghi is a cardiac imaging specialist, with above-average Medicare volume (top 13% in TX), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Razeghi experienced with office visit, established patient (30-39 min)?
Does Dr. Razeghi receive payments from pharmaceutical companies?
How do Dr. Razeghi's costs compare to other cardiovascular diseases in Cypress?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology